Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 12.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 877 shares of the biotechnology company’s stock after acquiring an additional 95 shares during the period. Concurrent Investment Advisors LLC’s holdings in Axon Enterprise were worth $521,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in AXON. Prestige Wealth Management Group LLC raised its holdings in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp raised its holdings in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 2.6 %

Axon Enterprise stock opened at $499.73 on Tuesday. The firm has a market cap of $38.11 billion, a PE ratio of 129.13, a P/E/G ratio of 5.43 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm’s 50 day moving average price is $616.95 and its two-hundred day moving average price is $520.78. Axon Enterprise, Inc. has a twelve month low of $265.32 and a twelve month high of $715.99.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on AXON shares. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a report on Thursday, February 20th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Get Our Latest Analysis on Axon Enterprise

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock valued at $5,631,561 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.